[Translation] A multicenter, double-blind, randomized, parallel, active-controlled Phase III trial to evaluate the efficacy and safety of INI101, an injectable botulinum toxin type A, compared with BOTOX® in subjects with moderate to severe glabellar lines
评价在中国的中至重度眉间纹成年受试者中,使用试验药物INI101在注射后4周的最大皱眉时眉间纹改善率是否非劣于对照药品BOTOX®。
[Translation] To evaluate whether the investigational drug INI101 is non-inferior to the control drug BOTOX® in the rate of improvement of glabellar lines at maximum frown 4 weeks after injection in adult subjects with moderate to severe glabellar lines in China.